Precision Biosciences (DTIL) EBT Margin (2018 - 2025)
Historic EBT Margin for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to 153861.54%.
- Precision Biosciences' EBT Margin fell 1504295900.0% to 153861.54% in Q3 2025 from the same period last year, while for Sep 2025 it was 12322.06%, marking a year-over-year decrease of 123073100.0%. This contributed to the annual value of 30.83% for FY2024, which is 477300.0% up from last year.
- Per Precision Biosciences' latest filing, its EBT Margin stood at 153861.54% for Q3 2025, which was down 1504295900.0% from 117327.78% recorded in Q2 2025.
- Precision Biosciences' EBT Margin's 5-year high stood at 50.96% during Q2 2024, with a 5-year trough of 153861.54% in Q3 2025.
- In the last 5 years, Precision Biosciences' EBT Margin had a median value of 188.9% in 2022 and averaged 18638.77%.
- As far as peak fluctuations go, Precision Biosciences' EBT Margin surged by 30649600bps in 2021, and later crashed by -1504295900bps in 2025.
- Quarter analysis of 5 years shows Precision Biosciences' EBT Margin stood at 484.52% in 2021, then soared by 79bps to 100.57% in 2022, then tumbled by -93bps to 193.83% in 2023, then plummeted by -1820bps to 3721.63% in 2024, then plummeted by -4034bps to 153861.54% in 2025.
- Its EBT Margin stands at 153861.54% for Q3 2025, versus 117327.78% for Q2 2025 and 72906.9% for Q1 2025.